NIT
AUPH icon

NumerixS Investment Technologies’s Aurinia Pharmaceuticals AUPH Stock Holding History

NumerixS Investment Technologies’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,600
Closed -$29K – 1127
2017
Q3 		$29K Sell
4,600
-21,300
-82% -$134K 0.01% 1010
2017
Q2 		$159K Sell
25,900
-28,755
-53% -$194K 0.02% 719
2017
Q1 		$401K Buy
+54,655
New +$252K 0.05% 498

Other funds holding AUPH

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

NumerixS Investment Technologies's AUPH Position: Q4 2017 in Review

NumerixS Investment Technologies sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2017, closing a stake of 4,600 shares — an estimated $29K sold.

NumerixS Investment Technologies first reported a position in AUPH in Q1 2017 and held it in 3 quarters. The position peaked at $401K in Q1 2017. 68 funds tracked by Wall St. Rank hold AUPH as of Q4 2017.

  • NumerixS Investment Technologies reported no remaining Aurinia Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • NumerixS Investment Technologies sold 4,600 Aurinia Pharmaceuticals shares in Q4 2017, an estimated $29K.
  • NumerixS Investment Technologies first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 3 quarters.
  • NumerixS Investment Technologies's Aurinia Pharmaceuticals position peaked at $401K in Q1 2017.
  • 68 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2017.

Based on NumerixS Investment Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.